IDVO - ETF AI Analysis

Top Page

Amplify International Enhanced Dividend Income ETF (IDVO)

Rating:69Neutral

Price Target:―

IDVO, the Amplify International Enhanced Dividend Income ETF, has a solid overall rating driven by high-quality international leaders like TSMC and AstraZeneca, which benefit from strong financial performance, positive earnings calls, and strategic positioning in advanced technologies and healthcare. Large financial holdings such as Mitsubishi UFJ, Sumitomo Mitsui, and Barclays also support the fund’s rating with solid revenue growth, reasonable valuations, and dividend income, though some face leverage, cash flow, and loan-loss risks. The main risk factor is the fund’s significant exposure to financial institutions, which can be sensitive to economic and credit conditions.

Positive Factors

Strong Recent Performance

The ETF has shown strong gains over the past month, three months, and year-to-date, indicating solid recent momentum.

Healthy Top Holdings

Most of the largest positions, including major financial, technology, and healthcare names, have delivered positive year-to-date performance that supports the fund.

Broad Sector Diversification

Holdings spread across financials, materials, industrials, technology, energy, healthcare, and other sectors help reduce the impact of weakness in any single industry.

Negative Factors

Relatively High Expense Ratio

The fund’s expense ratio is on the higher side for an ETF, which can modestly reduce net returns over time.

Heavy U.S. Exposure

Despite being an international-focused strategy, the portfolio is heavily tilted toward U.S. securities, limiting the benefits of global diversification.

Mixed Performance Among Top Holdings

While most top holdings are performing well, at least one significant position has been weak year-to-date, which can drag on overall results if that continues.

IDVO vs. SPDR S&P 500 ETF (SPY)

AUM1.02B

RegionGlobal Ex-U.S.

Expense Ratio0.65%

Beta0.78

IssuerAmplify

Inception DateSep 08, 2022

Dividend Yield5.45%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume435,514

30 Day Avg. Volume445,399

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

43.22

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering52

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IDVO Summary

The Amplify International Enhanced Dividend Income ETF (IDVO) is an actively managed fund (no fixed index) that focuses on international companies paying attractive dividends. It holds a mix of sectors like financials, materials, and technology, with major positions in well-known names such as Alibaba, TSMC, Novartis, and AstraZeneca. Investors might consider IDVO to seek regular income from dividends while adding global diversification beyond the U.S. market. However, the fund’s value and income can go up and down with international markets and currency movements, and it is fairly concentrated in financial stocks.

How much will it cost me?The Amplify International Enhanced Dividend Income ETF (IDVO) has an expense ratio of 0.66%, which means you’ll pay $6.60 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on enhancing dividend income through a diversified global portfolio.

What would affect this ETF?The Amplify International Enhanced Dividend Income ETF (IDVO) could benefit from global economic growth, particularly in sectors like technology and financials, which are heavily weighted in its portfolio. However, it may face challenges from rising interest rates, which could impact dividend-paying stocks, and geopolitical tensions or regulatory changes in the international markets where it operates. Diversification across sectors and regions provides some resilience, but exposure to specific companies like Alibaba and TSMC means performance could be influenced by trends in e-commerce and semiconductor industries.

IDVO Top 10 Holdings

IDVO leans heavily on international financials, with Japanese banks like Sumitomo Mitsui and Mitsubishi UFJ, plus Canada’s Bank of Montreal, acting as steady engines and recently rising to support the fund. Health care is another quiet powerhouse, as Novartis and AstraZeneca have been climbing and adding defensive ballast. TSMC brings a dose of high-powered tech momentum, helping performance but also adding some volatility risk. On the weaker side, Alibaba has been lagging, occasionally throwing sand in the gears. Overall, this is a global ex-U.S. income play, not a U.S. Big Tech story.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
	―	4.96%	$50.76M	―	―	―
TSM	TSMC	4.14%	$42.35M	$1.51T	94.33%	81 Outperform
NTR	Nutrien	4.11%	$42.06M	C$54.75B	63.12%	75 Outperform
BMO	Bank Of Montreal	3.19%	$32.65M	C$131.46B	39.90%	74 Outperform
BABA	Alibaba	3.17%	$32.43M	$284.78B	-4.17%	68 Neutral
CCO	Cameco	3.06%	$31.28M	C$64.52B	154.11%	71 Outperform
E	Eni SPA	3.00%	$30.68M	$74.84B	71.31%	79 Outperform
MUFG	Mitsubishi UFJ	2.74%	$28.04M	$186.22B	20.28%	77 Outperform
SIEGY	Siemens AG	2.59%	$26.44M	$192.30B	-0.27%	78 Outperform
AZN	AstraZeneca	2.52%	$25.77M	$295.60B	19.89%	80 Outperform

IDVO Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

41.50

Negative

100DMA

39.38

Positive

200DMA

36.70

Positive

Market Momentum

MACD

-0.45

Positive

RSI

41.31

Neutral

STOCH

28.35

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IDVO, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 41.78, equal to the 50-day MA of 41.50, and equal to the 200-day MA of 36.70, indicating a neutral trend. The MACD of -0.45 indicates Positive momentum. The RSI at 41.31 is Neutral, neither overbought nor oversold. The STOCH value of 28.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IDVO.

IDVO Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IDVO	―	―	$1.02B	0.65%	69 Neutral
ILOW	―	―	$1.65B	0.50%	60 Neutral
CGIC	―	―	$1.48B	0.54%	61 Neutral
WCMI	―	―	$1.03B	0.85%	61 Neutral
APIE	―	―	$953.43M	0.45%	65 Neutral
MFSI	―	―	$879.37M	0.59%	66 Neutral

Performance Comparison

IDVO

Amplify International Enhanced Dividend Income ETF

40.31

9.51

30.88%

ILOW

AB International Low Volatility Equity ETF

―

CGIC

Capital Group International Core Equity ETF

―

WCMI

First Trust WCM International Equity ETF

―

APIE

ActivePassive International Equity ETF

―

MFSI

MFS Active International ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents